Boston Scientific Provides Preliminary Q2 Results
Jul 3, 2003
 Print this page

Boston Scientific Corporation announced preliminary, unaudited financial results for the second quarter. According to the company, preliminary net sales for the second quarter were U.S. $852 million, as compared to $708 million for the second quarter of 2002, an increase of 20 percent. Excluding the favorable impact of foreign currency fluctuations, net sales were reported at $813 million, an increase of 15 percent. Excluding net special charges, the company currently estimates earnings per share (diluted) for the second quarter of 2003 of between $0.29 and $0.30, as compared to $0.23 per share for the second quarter of 2002, an increase of between 26 and 30 percent. The preliminary estimated net special charges for the quarter of $11 million (after-tax), or approximately $0.03 per share, include purchased research and development related to acquisitions, the company said.

Back to Breaking News